SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Kosovo -- Ignore unavailable to you. Want to Upgrade?


To: Emile Vidrine who wrote (4740)4/20/1999 8:02:00 PM
From: goldsnow  Respond to of 17770
 
In a presentation
at the International Congress on
Schizophrenia Research today,
Donald C. Goff, M.D., principal
investigator, reported results of a
clinical trial with CX516
(Ampalex(R)) in 19 patients with
schizophrenia. Dr. Goff is Director
of the Psychotic Disorders
Program at Massachusetts General
Hospital in Boston.
infoseek.go.com